Inventor · disambiguated record
Paul Chamberlin
Also filed as: CHAMBERLIN PAUL · CHAMBERLIN PAUL G
9 granted patents·9 pending applications·24 citations·filing 2014–2025
84Inventor score
Top patents by PatentIndex Score
18 records- 0193US11793807B2Methods of treating heart failure with preserved ejection fraction using modified forms of trimetazidineIMBRIA PHARMACEUTICALS INC·Filed 2021·Granted Oct 24, 2023·4 cites·20 claims
- 0292US11883396B2Methods of treating kidney conditions using modified forms of trimetazidineIMBRIA PHARMACEUTICALS INC·Filed 2022·Granted Jan 30, 2024·2 cites·20 claims
- 0391US11969422B2Methods of treating heart failure with reduced ejection fraction using modified forms of trimetazidineIMBRIA PHARMACEUTICALS INC·Filed 2021·Granted Apr 30, 2024·3 cites·18 claims
- 0491US11730733B2Methods of treating non-obstructive hypertrophic cardiomyopathy using modified forms of trimetazidineIMBRIA PHARMACEUTICALS INC·Filed 2021·Granted Aug 22, 2023·2 cites·11 claims
- 0589US9590128B2Particle detector and method of detecting particlesLITHIUM INNOVATIONS COMPANY LLC·Filed 2015·Granted Mar 7, 2017·12 cites·25 claims
- 0686US12076318B2Methods of treating heart failure with hibernating myocardium using modified forms of trimetazidineIMBRIA PHARMACEUTICALS INC·Filed 2021·Granted Sep 3, 2024·1 cites·18 claims
- 0780US12285428B2Methods of treating kidney conditions using modified forms of trimetazidineIMBRIA PHARMACEUTICALS INC·Filed 2023·Granted Apr 29, 2025·0 cites·20 claims
- 0878US12502389B2Methods of treating heart failure with preserved ejection fraction using modified forms of trimetazidineIMBRIA PHARMACEUTICALS INC·Filed 2023·Granted Dec 23, 2025·0 cites·20 claims
- 0978US12233058B2Methods of treating non-obstructive hypertrophic cardiomyopathy using modified forms of trimetazidineIMBRIA PHARMACEUTICALS INC·Filed 2023·Granted Feb 25, 2025·0 cites·9 claims
- 1072US2024245678A1Methods of treating heart failure with reduced ejection fraction using modified forms of trimetazidineIMBRIA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1172US2024374584A1Methods of treating heart failure with hibernating myocardium using modified forms of trimetazidineIMBRIA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1270US2025221986A1Methods of treating kidney conditions using modified forms of trimetazidineIMBRIA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1363US2025152581A1Methods of treating non-obstructive hypertrophic cardiomyopathy using modified forms of trimetazidineIMBRIA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1457US2025235447A1Methods for treating cardiovascular conditions and methods of increasing the efficiency of cardiac metabolismIMBRIA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1555US2024082242A1Combination therapiesIMBRIA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1651US2020038454A1Methods and compositions for tissue therapy and analysisVENTRIX INC·Filed 2019·Application pending·0 cites
- 1748US2023210845A1Dosing methods for treatment of cardiovascular conditionsIMBRIA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1847US2016000834A1Methods and compositions for tissue therapy and analysisVENTRIX INC·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →